Showing results (161-170 of 170) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Nature Communications|April 12, 2023
A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungiThaila Fernanda Dos Reis, Patrícia Alves de Castro, Rafael Wesley Bastos, et al.Cells|January 21, 2023
SGC-CAMKK2-1: A Chemical Probe for CAMKK2Carrow Wells, Yi Liang, Thomas L Pulliam, et al.BMC Medical Research Methodology|September 4, 2023
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trialKamala Thriemer, Robert James Commons, Megha Rajasekhar, et al.Journal of Medicinal Chemistry|July 15, 2021
Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor ChemotypesBenjamin J Eduful, Sean N O'Byrne, Louisa Temme, et al.Biorxiv : the Preprint Server for Biology|April 2, 2024
Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approachEric M Merten, John D Sears, Tina M Leisner, et al.Research Square|November 28, 2024
A Covalent Chemical Probe for <i>Chikungunya</i> nsP2 Cysteine Protease with Antialphaviral Activity and Proteome-wide SelectivityAnirban Ghoshal, Edwin G Tse, Mohammad Anwar Hossain, et al.Scientific Reports|March 2, 2025
A covalent chemical probe for Chikungunya nsP2 cysteine protease with antialphaviral activity and proteome-wide selectivityAnirban Ghoshal, Edwin G Tse, Mohammad Anwar Hossain, et al.Plos Neglected Tropical Diseases|September 6, 2023
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiencyWalter R J Taylor, Niamh Meagher, Benedikt Ley, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 2024
Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approachEric M Merten, John D Sears, Tina M Leisner, et al.Lancet (London, England)|July 23, 2019
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trialWalter R J Taylor, Kamala Thriemer, Lorenz von Seidlein, et al.Pageof 17